These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 2504222

  • 21. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin.
    Kalivas PW, Bronson M.
    Neuropharmacology; 1985 Oct; 24(10):931-6. PubMed ID: 3934576
    [Abstract] [Full Text] [Related]

  • 25. Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens.
    Cador M, Taylor JR, Robbins TW.
    Psychopharmacology (Berl); 1991 Oct; 104(3):377-85. PubMed ID: 1924645
    [Abstract] [Full Text] [Related]

  • 26. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P, Robbins TW.
    Neuropharmacology; 1985 Jan; 24(1):25-31. PubMed ID: 3920545
    [Abstract] [Full Text] [Related]

  • 27. Apomorphine-induced facilitation of intracranial self-stimulation following dopamine denervation of the nucleus accumbens.
    Strecker RE, Roberts DC, Koob GF.
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1015-8. PubMed ID: 6817349
    [Abstract] [Full Text] [Related]

  • 28. Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity.
    Joyce EM, Stinus L, Iversen SD.
    Neuropharmacology; 1983 Sep; 22(9):1141-5. PubMed ID: 6415508
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.
    Kelly PH, Seviour PW, Iversen SD.
    Brain Res; 1975 Sep 05; 94(3):507-22. PubMed ID: 1171714
    [Abstract] [Full Text] [Related]

  • 31. Effect of angiotensin II on passive avoidance performance after bilateral lesion of the nucleus accumbens septi.
    Winnicka MM, Braszko J, Boguszewicz J, Wiśniewski K.
    Pol J Pharmacol Pharm; 1985 Sep 05; 37(6):897-901. PubMed ID: 3938538
    [Abstract] [Full Text] [Related]

  • 32. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C, Fibiger HC, Phillips AG.
    Brain Res; 1982 Dec 16; 253(1-2):185-93. PubMed ID: 6817850
    [Abstract] [Full Text] [Related]

  • 33. Selective depletion of cortical noradrenaline by anti-dopamine beta-hydroxylase-saporin impairs attentional function and enhances the effects of guanfacine in the rat.
    Milstein JA, Lehmann O, Theobald DE, Dalley JW, Robbins TW.
    Psychopharmacology (Berl); 2007 Jan 16; 190(1):51-63. PubMed ID: 17096085
    [Abstract] [Full Text] [Related]

  • 34. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF, Simon H, Herman JP, Le Moal M.
    Brain Res; 1984 Jun 15; 303(2):319-29. PubMed ID: 6430466
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Disinhibition of nucleus accumbens neurons by the dopamine D2 receptor agonist LY-141865: prevented by 6-OHDA pretreatment.
    Hu XT, Wang RY.
    Brain Res; 1988 Mar 22; 444(2):389-93. PubMed ID: 2965961
    [Abstract] [Full Text] [Related]

  • 40. Dopamine denervation of frontal cortex or nucleus accumbens does not affect ACTH-induced grooming behaviour.
    Dunn AJ, Alpert JE, Iversen SD.
    Behav Brain Res; 1984 Jun 22; 12(3):307-15. PubMed ID: 6087843
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.